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Clinacanthus nutans Lindau leaves (CN) have been used in traditional medicine but the therapeutic potential has not been explored
for cancer prevention and treatment. Current study aimed to evaluate the antioxidant and antiproliferative effects of CN, extracted
in chloroform, methanol, and water, on cancer cell lines. Antioxidant properties of CN were evaluated using DPPH, galvinoxyl,
nitric oxide, and hydrogen peroxide based radical scavenging assays, whereas the tumoricidal effect was tested on HepG2, IMR32,
NCL-H23, SNU-1, Hela, LS-174T, K562, Raji, and IMR32 cancer cells using MTT assay. Our data showed that CN in chloroform
extract was a good antioxidant against DPPH and galvinoxyl radicals, but less effective in negating nitric oxide and hydrogen
peroxide radicals. Chloroform extract exerted the highest antiproliferative effect onK-562 (91.28±0.03%) andRaji cell lines (88.97±
1.07%) at 100𝜇g/ml and the other five cancer cell lines in a concentration-dependent manner, but not on IMR-32 cells. Fourteen
known compounds were identified in chloroform extract, which was analysed by gas chromatography—mass spectra analysis.
In conclusion, CN extracts possess antioxidant and antiproliferative properties against cultured cancer cell lines, suggesting an
alternate adjunctive regimen for cancer prevention or treatment.
1. Introduction
Cancer remains one of the major health threats to Malaysian
population. Statistics have shown that the annual mortality
rate of cancer patients in hospitals of Malaysian Ministry
of Health has consistently reached 10-11% since 2006 [1].
Increasing evidence has demonstrated that tumorigenesis
is closely associated with elevated level of intracellular free
radicals, the reactive oxygen/nitrogen species (RONS), which
trigger cancer initiation and progression [2–4]. RONS are
commonly generated as metabolic by-products in normal
cells and have an indispensable role in redox-mediated
signaling. However, RONS level needs to be maintained
through a redox homeostasis to keep the basal RONS
below cytotoxic level. Uncontrolled RONS production over-
whelming the endogenous antioxidant capacity will result
in detrimental damage to cellular protein, lipid, and DNA,
leading to genomic instability, and ultimately promotes
cancer formation [5–7]. Evidence has shown that oncogene
activation, increased metabolic activity, and mitochondrial
malfunction are common causes which are responsible for
substantial surge in cellular RONS level [8]. Therefore,
scavenging RONSwith antioxidant supplement could salvage
cells from oxidative stress and prevent cancer growth and
expansion. This benefit had also been seen in patients at
risk of breast cancer, who were saved from the disease by
taking antioxidant supplement, such as carotenoids [9]. With
advances in cancer research, many molecular targeted drugs
have been introduced and showed promising outcome with
little side effects. However the use has also been limited
by genomic instability and drug resistance characteristics in
certain cancer cells. Thus, interest has been shifted to study
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traditional herbs as alternate anticancer regimens due to its
multitargeted characteristics. Hence, we sought to evaluate
Clinacanthus nutans Lindau for its potential to be used as
natural nutraceuticals for cancer prevention and treatment.
Clinacanthus nutans Lindau (CN), also known as Sabah
SnakeGrass, from the family Acanthaceae, is a type of famous
medicinal plants in Thai folklore medicine. Previously, CN
has traditionally been used to treat inflammation [10] and
viral infection [11, 12]. The use of this herb has also been
translated in clinics to treat herpes infection inThailand [13].
The cholophyll derivatives (phaeophytins) of CN chloroform
extracts contained 132-hydroxy-(132-R)-phaeophytin b, 132-
hydroxy-(132-S)-phaeophytin a, and 132-hydroxy-(132-R)-
phaeophytin and exhibited antiherpes simplex activity [14],
potentially through herpes virus inactivation and inhibition
preinfection [15]. Despite all the known biological activities
from previous work, emerging lay testimonies andMalaysian
newspaper reports suggested that CN possesses antitumor
effects andhad savedmany of various cancers.However, these
testimonies were not supported by scientific evidence. We
hypothesize that CN derivatives could be a source of cyto-
protective antioxidant based anticancer regimen. Hence, the
main objective in this study was to examine the antioxidant
and cytotoxicity effects of C. nutans on cancer cell lines.
2. Methods and Materials
2.1. Chemicals. 1,1-diphenyl-2-picrylhydrazyl (DPPH) rad-
ical, galvinoxyl radical, 6-hydroxy-2,5,7,8-tetramethylchro-
man-2-carboxylic acid (Trolox), phosphate buffer saline
(PBS), trypan blue, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphen-
yltetrazolium bromide (MTT), and 10x trypsin-EDTA solu-
tionwere purchased fromSigmaChemical Co. Ltd.,Malaysia.
Hydrogen peroxide and sodium nitroprusside (SNP) were
purchased from Merck, Malaysia. All the cancer cell lines,
including human liver hepatocellular carcinoma (HepG2),
human neuroblastoma cell line (IMR-32), human lung cancer
cell line (NCI-H23), human gastric cancer cell line (SNU-
1), human colon adenocarcinoma cell line (LS-174T), human
erythroleukemia cell line (K-562), human cervical cancer cell
line (HeLa), and human Burkitt’s lymphoma cell line (Raji),
were purchased from the American Type Culture Collec-
tion (ATCC, Rockville, MD), while human umbilical veins
endothelial cells (HUVECs) were obtained from Cascade
Biologics, Inc. (Portland).
2.2. Plant Materials. Whole plant of Clinacanthus nutans
(Burm.f.) Lindau was harvested in November 2011 from
botanical garden in Serdang, Selangor, Malaysia. The botan-
ical identify of C. nutans was characterized by the Phy-
tomedicinal Herbarium, Institute of Bioscience, Universiti
Putra Malaysia, Selangor (Voucher no. SK1980/11).
2.3. Preparation of Extracts. TheC. nutans leaves were freshly
harvested and oven-dried at 40–45∘C. The leaves were then
ground into powder and sequentially soaked in chloroform
(CNC), methanol (CNM), and distilled water (CNA) at room
temperature. The extracts in all three solvents were collected
separately in clean glass bottles. Extracts were then filtered
using Whatman no. 1 paper. The filtrates in chloroform
and methanol were dried by using rotary evaporator, while
filtrates in distilled water were dried with a freeze drier. All
the extracts were kept at 20∘C until use.
2.4. Determination of Antioxidant Properties
2.4.1. DPPH Radical Scavenging Assay. DPPH radical scav-
enging activity of the tested extracts was determined accord-
ing to the method described by Chan et al. [16] with slight
modifications. In brief, each extract solution (50 𝜇L), after
serially diluted in ethanol to 12.5, 25, 50, and 100 𝜇g/mL, was
mixed with 195 𝜇L of DPPH ethanolic solution (0.2mM).
Then, the mixtures were swirled gently for 1min and kept
in dark for 60min. The DPPH radical scavenging activity of
each extract was determined by electron spin resonance spec-
trometry (JEOL-JES-FA100, Tokyo, Japan) using the follow-
ing parameters: sweeping field, 340.047 ± 5mT; microwave
power, 4mW; modulation width, 0.1mT; sweep time, 30 s;
time constant, 0.1 s; and amplitude, 160. Trolox was used as
the standard and DPPH radical scavenging activity of each
extract was expressed as 𝜇g Trolox equivalent/g extract.
2.4.2. Galvinoxyl Radical Scavenging Activity. In order to
determine the galvinoxyl radical scavenging activity of each
extract. Extracts were serially diluted to 12.5, 25, 50, and
100 𝜇g/mL solutions in ethanol, and each of them (50 𝜇L) was
mixed with 150𝜇L of galvinoxyl radical ethanolic solution
(0.125mM). Then, the mixture was swirled gently for 1min
and kept in the dark for 60min. Galvinoxyl radical scaveng-
ing activity of each extract was determined by electron spin
resonance spectrometry (JEOL-JES-FA100, Tokyo, Japan)
using the following parameters: sweeping field, 340.047 ±
5mT; microwave power, 4mW; modulation width, 0.2mT;
sweep time, 30 s; time constant, 0.1 s; and amplitude, 120.
Trolox was used as the standard and galvinoxyl radical
scavenging activity of each extract was expressed as 𝜇g Trolox
equivalent/g extract.
2.4.3. Nitric Oxide (NO) Radical Scavenging Assay. Sodium
nitroprusside (SNP) spontaneously generated nitric oxide
(NO) by interacting with oxygen in aqueous solution at
physiological pH (pH 7.4). Scavenger of NO will eventually
reduce the production of nitrite ion in solution which can
be determined by the use of Griess reagent. Briefly, each
extract (50𝜇L) of various concentrations (12.5, 25, 50, and
100 𝜇g/mL) was mixed with equal volume of SNP (10mM
final concentration), in phosphate buffer saline (PBS) and
incubated at room temperature for 150min [17]. DMSO
in distilled water (0.1%) without the extract served as the
negative control and quercetin was used as a positive control.
After incubation, the samples from the above were reacted
with equal volume of Griess reagent (1% sulphanilamide,
0.1% naphthylethylenediamine dichloride, and 3% phospho-
ric acid). The absorbance of the chromophore which was
formed in the reaction was measured at 550 nm against
the corresponding control. The amount of nitrite in the
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samples was calculated from sodium nitrite standard curve
(0–100𝜇M).
2.4.4. Scavenging Activity of Hydrogen Peroxide. All three
extracts of C. nutans leaves were tested for scavenging poten-
tial against hydrogen peroxide according to the Ruch et al.
[18]. Briefly, sample extract (2mL) with different concentra-
tion (12.5, 25, 50, and 100 𝜇g/mL) was mixed with hydrogen
peroxide (H
2
O
2
) solution (1.2mL, 40mM) in phosphate
buffer (pH 7.4). The mixture was incubated for 10 min, and
the absorbance was measured at 230 nm. An equal volume of
distilled water without H
2
O
2
served as blank.The scavenging
activity of each extract was calculated by using the formula as
follows: % scavenging activity = [(𝐴
𝑐
−𝐴
𝑡
)/𝐴
𝑐
] × 100, where
𝐴
𝑐
indicates the absorbance of the control and 𝐴
𝑡
represents
the absorbance of the extract.
2.5. Cell Culture. Three different extracts were tested on eight
human cancer cell lines, including human liver hepatocellular
carcinoma (HepG2), human neuroblastoma cell line (IMR-
32), human lung cancer cell line (NCI-H23), human gastric
cancer cell line (SNU-1), human colon adenocarcinoma cell
line (LS-174T), human erythroleukemia cell line (K-562),
human cervical cancer cell line (HeLa), human Burkitt’s lym-
phoma cell line (Raji) and normal cell, and human umbilical
veins endothelial cells (HUVECs) for their antiproliferative
activity. All the cell lines were maintained in RPMI 1640 or
DMFmedium containing 10% (v/v) fetal bovine serum (FBS)
supplemented with penicillin (100U/mL) and streptomycin
(100 𝜇g/mL), except HUVECs which were grown in M200
supplemented with low serum growth supplement at 37∘C
under humidified atmosphere containing 5% CO
2
in the
incubator.
2.6. Antiproliferation Assay. Antiproliferative activity of the
three extracts was examined by using MTT assay [19].
Briefly, cells (6 × 103 cells/mL) were seeded in 96-well, flat
bottomed plate and treated with three different extracts at
a concentration range from 3.125 to 100 𝜇g/mL after cells
were incubated at 37∘C in a humidified 5% CO
2
/95% air
mixture for overnight. After 72 h of posttreatment, 20𝜇L
of 0.5% 3(4,5-dimethyl-thiazol-2-yl)2,5-diphenyltetrazolium
bromide (MTT) solution in phosphate buffer saline (PBS)
was added to each well and incubated for additional 4 h
in 5% CO
2
humidified incubator. The plate was centrifuged
at 3000 rpm for 10min and the supernatant was removed.
The formazan crystals in each well were dissolved by adding
100 𝜇L of dimethyl sulfoxide (DMSO). The amount of purple
formazan produced relative to number of viable cells was
determined by measuring the absorbance with a microplate
spectrophotometer reader at 550 nm. For CN treated cells,
viability was expressed as a percentage of control cells. All the
assays were carried out in triplicate and in three independent
tests. All the extracts were dissolved in DMSO at final
concentration less than 0.1%. Under these conditions, DMSO
was not toxic to all the cancer cell lines mentioned above.
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Figure 1: DPPH and galvinoxyl radical scavenging activity of
various solvent extracts of Clinacanthus nutans leaves. Results
represent mean ± SEM (𝑛 = 3).
2.7. GC-MS Analysis. CNC was analyzed by gas chromatog-
raphy equipped with mass spectrometry (GC-MS-QP2010
Plus-Shimadzu). The column temperature was set to 50∘C
for 4min, then increased to 320∘C at the rate of 7∘C/min,
and then held for 20min. The injector temperature was set
at 280∘C (split mode with the ratio being adjusted to 20 : 1,
injection volume = 0.1 𝜇L). The flow rate of the helium
carrier gas was set to 1mL/min. Total run time was 60min.
Mass spectra were obtained from the range m/e 40 to 700
and the electron ionization at 70 eV. The chromatograms of
the sample were identified by comparing their mass spectra
with NIST08 library data, and the GC retention time against
known standards.
2.8. Statistical Analysis. All the data presented in mean ±
standard error of mean (SEM) and performed by using the
Statistical Package for Social Sciences (SPSS 16). Data were
analyzed by one-way ANOVA, followed by Dunnett’s test.
𝑃 < 0.05 was considered to be significant.
3. Results
3.1. DPPH Radicals Scavenging Activity. DPPH has been
widely used to measure the antioxidant property of various
samples including fruits, beverages, and even plant extracts.
In the current study, Trolox was used as standard, and hence
the antioxidant capacity of an extract will be expressed in
𝜇g Teq/g extract. Figure 1 illustrates that the CNC was found
to exhibit the highest DPPH scavenging activity compared
to CNM and CNA with an antioxidant capacity value,
7852.63 ± 449.90 𝜇g Teq/g extract. However, CNA showed
the lowest activity with antioxidant capacity value 864.11 ±
73.49 𝜇g Teq/g extract. The antioxidant activity of the C.
nutans extracts decreased in the order of chloroform >
methanol > aqueous.
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Figure 2: Percentage scavenging activity of nitric oxide radicals
in response to C. nutans extracts in different solvents at different
concentrations.The reactionwas performed in triplicates and results
were expressed in % inhibition (mean ± SEM).
3.2. Galvinoxyl Scavenging Activity. Galvinoxyl radical scav-
enging activity of serially extraction of C. nutans was evalu-
ated as the samemanner of DPPHwhere the Trolox was used
as standard and the absorbance was measured by using ESR
spectra. Figure 1 showed the galvinoxyl radical scavenging
activity of three types of extractions. Chloroform extract
possessed the highest scavenging activity with the value
of 12248.82 ± 173.50 𝜇g Teq/g extract. Moreover, a similar
order was observed where the order of galvinoxyl radical
scavenging activity was chloroform >methanol > aqueous.
3.3. Nitric Oxide Scavenging Activity. Figure 2 showed the
nitric oxide (NO) scavenging activity of three different
extracts of C. nutans leaves. It was observed that only CNA
has the ability to scavenge nitric oxide radical and was
in the concentration dependent manner. The highest NO
scavenging activity of 32.33 ± 0.97% was observed using
100 𝜇g/mL of CNA. Nitrite content was significantly higher
in CNM at 100𝜇g/mL with NO scavenging activity of 18.51±
8.24%.
3.4. Hydrogen Peroxide Scavenging Activity. In this study,
CNC, CNM, and CNA showed relatively poor hydrogen
peroxide scavenging activities, albeit CNM being the most
effective hydrogen peroxide scavenger which showed ∼34%
scavenging activity at 100 𝜇g/mL (Figure 3).
3.5. Antiproliferative Effect of C. nutans Extracts on the
Growth of Tumor Cells. Theantiproliferative activity of theC.
nutans extracts against human liver hepatocellular carcinoma
(HepG2), human neuroblastoma cell line (IMR-32), human
lung cancer cell line (NCI-H23), human gastric cancer cell
line (SNU-1), human colon adenocarcinoma cell line (LS-
174T), human erythroleukemia cell line (K-562), human cer-
vical cancer cell line (HeLa), and human Burkitt’s lymphoma
cell line (Raji) was shown in Table 1. Significant inhibition of
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Figure 3: Inhibition of hydrogen peroxide radicals. The data
represent the percentage of hydrogen peroxide radical inhibition
(mean ± SEM) and experiments were performed in triplicate.
cell proliferation was shown in HeLa and K-562 cells after
treated with the C. nutans extract in aqueous at 100 𝜇g/mL
(36.31 ± 1.52% and 40.94 ± 0.19%, resp.), but not the others.
Methanol extract of C. nutans showed no activity towards
four cancer cell lines, namely, the NCI-23, HeLa, K-562, and
Raji cell lines. CNM showed relatively weak antiproliferative
activity in IMR32, SNU-1, and LS-174T cell lines, although
41.88 ± 2.81% inhibitions were observed in HepG2 cell
lines at 100 𝜇g/mL exhibited. CNC was the most potent
antiproliferative agent against most cancer cell lines tested
in this experiment. CNC showed the highest antiproliferative
activity on K-562 and Raji cancer cell lines at 100 𝜇g/mL with
percentage inhibition of 91.28 ± 0.03% (IC
50
= 47.70 𝜇g/mL)
and 88.97 ± 1.07% (IC
50
= 47.31 𝜇g/mL), respectively.
However, no effect was observed in IMR 32 cell lines.
To test whether the extract is cytotoxic to normal cells,
human umbilical vein endothelial cells (HUVECs) were
treated with all CNC, CNM, and CNA at the highest test
concentration, which is 100𝜇g/mL.Thepercentage inhibition
was significantly lower in HUVECs compared to the other
cancer cells (𝑃 < 0.05) (Table 1).
3.6. GC-MS Analysis of Chloroform Extract. A GC-MS anal-
ysis was performed on chloroform extract of C. nutans,
which exhibited relatively higher activity in antioxidant and
anti-proliferative compared to the extracts in methanol and
aqueous (Figure 4). Fourteen chemical constituents were
identified, and the major chemical constituent was 1, 2-
benzenedicarboxylic acid, mono (2-ethylhexyl) ester with
relative peak area of 28.60% (Table 2). Previous reports
suggested that 1, 2-benzenedicarboxylic acid, mono (2-
ethylhexyl) ester has anti-microbial activity [20]. These phy-
tochemical may also contribute to the medicinal activity,
including antioxidant and antiproliferative properties.
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Figure 4: ((a), (b), and (c)) Phytochemical constituents detected using GC-MS, with relative retention time (𝑡𝑅) from chloroform extract of
C. nutans, (b) Enlarged from region I, and (c) Enlarged from region II.
4. Discussion
Past studies have shown that imbalance cellular redox
homeostasis with elevated free radical production is one
of the common causes of cancer initiation and progression
and many other diseases [21]. Increased free radicals, the
reactive oxygen species and reactive nitrogen species, in
cancer cells correlate with the rapid progression to tumour
development and promote metastasis, which often results in
poor prognosis. The current treatment for cancer patients,
such as chemotherapy and radiotherapy, may also contribute
to oxidative damage to the tumour cells as well as the adjacent
healthy cells. Many clinical trials have also suggested that
antioxidants can shield the healthy cells from oxidative stress
induced by these therapies, minimizing the subsequent side
effects in cancer patients [22–24]. Thus, scavenging the free
radicals with antioxidant may prove an alternate strategy to
protect normal healthy cells from DNA damage and limit
the progression of cancer cells. Nevertheless, accumulating
evidence has also suggested that adaptation to extreme oxida-
tive stress could occur in some transformed cancer cells [25].
These cancer cells could develop antioxidant defense system
with enhanced scavenging capacity and survive intrinsic
ROS toxicity through upregulation of survival proteins. For
instance, H-ras-transformed cells with increased superoxide
and hydrogen peroxide levels were noted with significant
upregulation of antioxidant enzymes peroxiredoxin-3 and
thioredoxin peroxidase [26]. This effect is likely to enable
cancer cells to evade ROSmediated apoptosis. Therefore, it is
possible that scavenging the radicals with exogenous antioxi-
dant alone may not be effective to eliminate the transformed
cancer. Furthermore, elevated ROS level in cancer cells were
found to affect neighboring cells to acquire uncontrolled ROS
production [27], through intercellular transfer of hydrogen
peroxide (H
2
O
2
). Hence, antioxidant is still needed to stop
ROS from spreading, and its role is more likely to salvage the
unaffected cells adjacent to transformed cancer cells and limit
tumour expansion.
Therefore, the concept of multitargeted therapy is intro-
duced to exploit the use of single regimen to exert com-
plex synergistic and antagonistic effects to act on multiple
pathophysiological pathways in order to achieve optimal
therapeutic outcome. Clinacanthus nutans (CN) leaves have
previously been known to have anti-inflammatory [28] and
antiviral properties [29, 30]. Recent report from Pannang-
petch et al. [31] also documented that ethanolic extract of
C. nutans leaves exhibited antioxidant activity and protective
effect against oxidative hemolysis; however, the study had
not been extended to investigate its antitumour properties.
Here, we examined the effects of CN extracted in three
different solvents: chloroform, methanol, and water. We
observed that CN contained antioxidant elements and was
capable of negating free radicals, after tested on diphenyl-1-
picrylhydrazyl (DPPH), galvinoxyl radical, nitric oxide, and
hydrogen peroxide scavenging assays, albeit with different
CN extracts. However, results fromDPPHwere contradicting
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Table 1: Anti-proliferative effect of chloroform, methanol and aqueous extract of C. nutans at various concentrations (3.125–100 𝜇g/mL) on
eight different types of tumorigenic cell lines and normal cell, human umbilical veins endothelial cells (HUVECs). The growth inhibitory
activity was normalized to control and expressed in percentage (%). Data represented in mean ± SEM in triplicate.
HepG2 IMR32 NCI-32 SNU-1 HeLa LS-174T K562 Raji HUVECs
Chloroform extract (𝜇g/mL)
3.125 16.65 ± 1.84∗ NA 27.03 ± 0.62∗ 6.63 ± 2.65 4.59 ± 0.83 21.78 ± 1.25∗ 9.46 ± 1.09 5.59 ± 1.18
6.25 21.78 ± 1.21∗ NA 33.30 ± 1.18∗ 15.16 ± 0.41∗ 8.47 ± 1.17 27.06 ± 1.04∗ 7.89 ± 0.35 15.47 ± 0.49∗
12.5 26.62 ± 0.73∗ NA 36.65 ± 1.38∗ 18.17 ± 0.41∗ 16.16 ± 0.35∗ 33.98 ± 1.15∗ 9.99 ± 1.09 24.53 ± 0.43∗
25 29.97 ± 0.79∗ NA 39.14 ± 0.69∗ 25.05 ± 0.68∗ 22.25 ± 0.19∗ 36.52 ± 0.70∗ 32.23 ± 1.06∗ 38.01 ± 0.28∗
50 32.49 ± 0.10∗ NA 42.08 ± 0.75∗ 27.98 ± 0.18∗ 38.30 ± 0.08∗ 39.15 ± 0.42∗ 66.75 ± 0.47∗ 56.77 ± 0.23∗
100 38.76 ± 1.72∗ NA 55.82 ± 1.23∗ 31.25 ± 1.09∗ 56.73 ± 0.12∗ 41.97 ± 0.94∗ 91.28 ± 0.02∗ 88.97 ± 1.06∗ 17.39 ± 3.49∗
Methanol extract (𝜇g/mL)
3.125 14.90 ± 1.41∗ NA NA NA NA NA NA NA
6.25 22.16 ± 0.92∗ NA NA NA NA 1.17 ± 0.68 NA NA
12.5 25.00 ± 0.67∗ NA NA 3.10 ± 1.49 NA 13.21 ± 1.79∗ NA NA
25 26.93 ± 0.52∗ 4.57 ± 2.41 NA 9.06 ± 1.24 NA 21.06 ± 0.25∗ NA NA
50 32.89 ± 1.50∗ 9.35 ± 0.75 NA 14.03 ± 1.32∗ NA 22.66 ± 0.89∗ NA NA
100 41.88 ± 2.81∗ 22.08 ± 1.22∗ NA 21.32 ± 1.43∗ NA 30.33 ± 0.91∗ NA NA 23.75 ± 1.49∗
Aqueous extract (𝜇g/mL)
3.125 4.02 ± 2.22 NA NA 8.16 ± 0.55 9.37 ± 1.69 NA NA NA
6.25 9.03 ± 0.56 NA NA 13.27 ± 0.24∗ 15.74 ± 1.06∗ NA 10.89 ± 0.49∗ NA
12.5 14.89 ± 0.38∗ NA NA 16.56 ± 0.62∗ 19.56 ± 1.34∗ NA 12.48 ± 0.33∗ NA
25 16.15 ± 0.62∗ 0.36 ± 0.39 NA 20.51 ± 0.58∗ 24.84 ± 1.08∗ NA 15.39 ± 0.42∗ NA
50 20.37 ± 0.65∗ 13.80 ± 0.70∗ NA 22.30 ± 1.00∗ 27.42 ± 0.97∗ NA 25.61 ± 0.83∗ NA
100 27.42 ± 0.80∗ 23.22 ± 0.63∗ NA 27.57 ± 1.66∗ 36.31 ± 1.51∗ NA 40.94 ± 0.19∗ NA 17.31 ± 0.84∗
∗
𝑃 < 0.05, (NA: no activity).
Table 2: Phyto-constituents identified in the chloroform extract of the leaves of C. nutans by GC-MS.
Peak Name of the compound Peak area (%) RT
1 n-Pentadecanol 1.26 22.338
2 Eicosane 0.75 22.441
3 1-Nonadecene 1.64 25.570
4 Heptadecane 0.54 25.652
6 Dibutylphthalate 0.71 28.226
7 n-Tetracosanol-1 1.72 28.493
8 Heneicosane 0.33 28.558
9 Behenic alcohol 1.56 31.156
10 1-Heptacosanol 1.33 33.602
12 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester 28.60 35.328
13 Nonadecyl heptafluorobutyrate 1.25 35.857
17 Eicosayl trifluoroacetate 1.10 37.949
24 1,2-Benzenedicarcoxylic acid, dinonyl ester 2.59 38.890
26 Phthalic acid, dodecyl nonylester 1.00 39.170
RT: retention time.
the data fromnitric oxide scavenging assay.Thismay attribute
to the solubility of the extracts in different testing system and
the stereoselectivity of the radicals may also contribute to
different antioxidant activity of the extract [32].
Emerging lay testimonies from cancer patients claimed
that the herbs could eliminate the disease, suggesting their
potential use for anticancer treatment. Our experiments
proved that CN, particularly the extracts in chloroform, is
capable of inhibiting cell proliferation of seven tested cancer
cell lines, namely, the HepG2, IMR32, NCL-H23, SNU-1,
HeLa, LS-174T, K562, and Raji cells. Although constituents
in CNC failed to suppress the proliferation of IMR32 cancer
cells, the inhibitory benefits could still be observed using
extracts in methanol and in water. In CNC treated K562
cells and Raji cells, the IC
50
values were 47.70 𝜇g/mL and
47.31 𝜇g/mL, which fall above the recommended IC
50
value
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by National Cancer Institute (NCI) for crude extract, which
is <20𝜇g/mL. Although this data suggests that CNC may
not be a strong anticancer regimen, the antioxidant and
cancer inhibitory properties demonstrated in this experiment
may still support the use of CNC as an alternate adjunctive
therapy for cancer prevention or treatment. GC-MS anal-
ysis presented the volatile components of CNC, showing
14 phytochemicals at various concentrations, of which 1,2-
benzenedicarboxylic acid, mono (2-ethylhexyl) ester being
themost abundant in the extract, a commonplasticizer which
was found to possess antimicrobial activity [33]. Further
studies are still needed to unveil the underlying mechanism
and specific bioactive compounds phytochemical responsible
for the observed activities.
5. Conclusion
In conclusion, chloroform extract ofC. nutans leaves contains
the most potent constituents capable of scavenging free
radical and inhibiting the growth of cultured cancer cell lines.
This observation suggests that phytochemical constituents
present in chloroform extract could be used as an alternate
adjunctive or chemopreventive regimen for patients at risk of
cancers. However, further investigation study to understand
the underlyingmechanism and in vivo testing of the observed
antitumor activity are needed to unveil its potential use in
cancer therapy.
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